Filters close
access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 11:00 AM EDT Released to reporters: 7-Jun-2024 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Letter to editor and response: Is neurocysticercosis a main cause of epilepsy?
Released: 7-Jun-2024 12:05 PM EDT
Letter to editor and response: Is neurocysticercosis a main cause of epilepsy?
International League Against Epilepsy

ILAE produced a podcast episode in 2023 in which Dr. Hector Garcia talked about neurocysticercosis as a main cause of epilepsy. Two researchers from Latin America wrote in and questioned how frequently this parasitic infection actually leads to epilepsy. Dr. Garcia responded.

Newswise: Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
Released: 7-Jun-2024 11:45 AM EDT
Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center has earned its most highly rated grant from the National Cancer Institute (NCI). The NCI renewed Roswell Park’s status as a Comprehensive Cancer Center - a designation held by less than 4% of cancer centers- awarding Roswell Park the highest possible “Exceptional” rating as it renewed a grant Roswell Park has successfully competed for since 1972.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 4:00 PM EDT Released to reporters: 7-Jun-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 4:00 PM EDT Released to reporters: 7-Jun-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Fat Molecule’s Inability to Bond with Shape-Shifting Protein in Cell’s Powerhouse Linked to an Inherited Metabolic Disease
Released: 7-Jun-2024 11:00 AM EDT
Fat Molecule’s Inability to Bond with Shape-Shifting Protein in Cell’s Powerhouse Linked to an Inherited Metabolic Disease
Johns Hopkins Medicine

By studying mutations in yeast and human cells, Johns Hopkins Medicine scientists say they have found that biochemical bonds between fats and proteins in the mitochondrion, the cell’s powerhouse, play a crucial role in how our cells produce energy.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 5:00 PM EDT Released to reporters: 7-Jun-2024 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Reproductive health counseling in young women with epilepsy: Room for improvement
Released: 7-Jun-2024 9:05 AM EDT
Reproductive health counseling in young women with epilepsy: Room for improvement
International League Against Epilepsy

Pediatric neurologists are not counseling young adults with epilepsy about reproductive issues as frequently as needed, according to a recent 10-year study. Some conversations, such as those about pregnancy and the potential effects of antiseizure medications, are almost nonexistent.

Released: 7-Jun-2024 8:05 AM EDT
Engineering Cancer’s End: Moffitt Scientists Say Bioengineering Will Change Our Ability to Research and Treat Cancer
Moffitt Cancer Center

Bioengineering is revolutionizing cancer research, and Moffitt Cancer Center is at the forefront of this transformative movement. Moffitt is the first National Cancer Institute-designated comprehensive cancer center with a dedicated bioengineering department. This area of science integrates engineering and physical sciences with oncology to change how we understand and treat this complex disease.

Newswise: Timing key for type 2 diabetes drug performance
Released: 7-Jun-2024 12:05 AM EDT
Timing key for type 2 diabetes drug performance
University of Adelaide

Researchers from the University of Adelaide could be closer to discovering a better way to use metformin, a common type 2 diabetes medication. Metformin, which has been a cornerstone in diabetes treatment since the 1960s, is typically taken with meals to reduce gastrointestinal side effects but new research is suggesting patients could see improved results if it’s taken before meals.

Newswise: Specialist scanning needed to help endo patients
Released: 7-Jun-2024 12:05 AM EDT
Specialist scanning needed to help endo patients
University of Adelaide

A review of existing research shows there is a growing benefit to using specialist scanning to diagnose endometriosis. Endometriosis affects 1 in 9 women and those assigned female at birth. However, it takes 6.4 years to diagnose using the conventional standard of surgical laparoscopy.

Newswise: Dangerous work, unmet health care needs add up to more deaths, negative health outcomes for Texas shrimpers, according to UTHealth Houston research
Released: 6-Jun-2024 4:50 PM EDT
Dangerous work, unmet health care needs add up to more deaths, negative health outcomes for Texas shrimpers, according to UTHealth Houston research
University of Texas Health Science Center at Houston

A dangerous work environment and limited access to health care are related to higher death rates and negative health outcomes among Texas shrimpers in the Gulf of Mexico, according to a new study from UTHealth Houston.

Newswise: UTEP Pharmacy Researchers Develop Potential Treatment for Fibrosis
Released: 6-Jun-2024 4:05 PM EDT
UTEP Pharmacy Researchers Develop Potential Treatment for Fibrosis
University of Texas at El Paso

Researchers at The University of Texas at El Paso are developing a new therapeutic approach that uses nanoparticles for the treatment of skin and lung fibrosis, conditions that can result in severe damage to the body’s tissues.

Newswise: High Blood Pressure in the Hospital: What Doctors Should Know
Released: 6-Jun-2024 3:05 PM EDT
High Blood Pressure in the Hospital: What Doctors Should Know
University of Utah Health

A new statement from the American Heart Association recommends a much more conservative approach to treating high blood pressure in acute care.

Released: 6-Jun-2024 3:05 PM EDT
Mayo Clinic: Bioterapias a través del electrospinning del mañana
Mayo Clinic

El futuro de la curación de enfermedades puede involucrar una jeringa, una fuente de alimentación de alto voltaje y soluciones de polímeros que se unen para diseñar tejidos. En este momento, investigadores de Mayo Clinic están estudiando estos diferentes elementos utilizando un electrohilador, un dispositivo que convierte fibras bioterapéuticas en una estructura — o plataforma — para tejer bioterapéuticos regenerativos.

Released: 6-Jun-2024 3:05 PM EDT
Mayo Clinic: Bioterapias via eletrofiação do amanhã
Mayo Clinic

O futuro da cura das doenças pode envolver uma seringa, uma fonte de alimentação de alta tensão e soluções poliméricas que se unem para projetar tecidos. No momento, pesquisadores da Mayo Clinic estão estudando esses diferentes elementos utilizando um eletrofiador, dispositivo que transforma fibras bioterapêuticas em uma estrutura — ou plataforma — para tecer bioterapêuticos regenerativos.

Released: 6-Jun-2024 3:05 PM EDT
مايو كلينك: العلاجات الحيوية المستقبلية المغزولة كهربائيًا
Mayo Clinic

روتشستر، ولاية مينيسوتا - قد يتضمن مستقبل علاج الأمراض استخدام إبرة، ومصدر كهربائي عالي الجهد، ومحاليل بوليمر يلتقون معًا لهندسة الأنسجة. يدرس باحثو مايو كلينك حاليًا هذه العناصر المختلفة باستخدام جهاز غزل كهربائي، وهو جهاز يحوّل الألياف العلاجية الحيوية إلى سقالة - أو قاعدة - لغزل العلاجات الحيوية المتجددة.

Newswise: It’s been 16 Years since sweet-spot brain stimulation slowed Parkinson’s progression for Hermitage man
Released: 6-Jun-2024 3:05 PM EDT
It’s been 16 Years since sweet-spot brain stimulation slowed Parkinson’s progression for Hermitage man
Vanderbilt University Medical Center

In 2008 at VUMC there were a group of doctors trying something unheard of on a handful of patients who signed up for their study. Half would receive deep brain stimulation (DBS) surgery in attempt to slow the progression of their early-stage Parkinson’s disease, and the others would not.

Newswise: discovery_logo.svg
Released: 6-Jun-2024 3:05 PM EDT
ECHO Discovery Webinar: Fish consumption during pregnancy and impacts on child health
Environmental influences on Child Health Outcomes NIH

Three investigators from the Environmental Influences on Child Health Outcomes (ECHO) Program will discuss their recent paper on fish consumption and omega-3 supplementation during pregnancy and recent guidance on fatty acid supplements to prevent preterm birth.

Newswise: Saint Louis University Nursing Professor Honored With Distinguished Researcher Award
Released: 6-Jun-2024 2:05 PM EDT
Saint Louis University Nursing Professor Honored With Distinguished Researcher Award
Saint Louis University

Verna Hendricks-Ferguson, Ph.D., the Irene Riddle Endowed Chair and tenure professor at the Trudy Busch Valentine School of Nursing, was honored with the 2024 Distinguished Researcher Award by the Oncology Nursing Society.

Newswise: 1920_060224-outloudmusicfestival-forpress-danielmacadangdang-8.jpg?10000
Released: 6-Jun-2024 1:05 PM EDT
Cedars-Sinai Designated LGBTQ+ Equality Leader
Cedars-Sinai

Cedars-Sinai has once again earned national recognition as an LGBTQ+ Healthcare Equality Leader.

Newswise: Mpox continues to circulate at low numbers among gay and bisexual men who have sex with men
5-Jun-2024 5:05 PM EDT
Mpox continues to circulate at low numbers among gay and bisexual men who have sex with men
University of California, Los Angeles (UCLA), Health Sciences

Mpox continues to circulate in the U.S. among gay and bisexual men who have sex with men. Though the number fell sharply to only 3 cases during the June through December 2023 multisite surveillance period compared to the previous highs, concern for its reemergence continues due to, among other things, incomplete knowledge among other groups.

Newswise: Artificial Intelligence Blood Test Provides a Reliable Way to Identify Lung Cancer
Released: 6-Jun-2024 12:15 PM EDT
Artificial Intelligence Blood Test Provides a Reliable Way to Identify Lung Cancer
Johns Hopkins Medicine

Using artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer, researchers from the Johns Hopkins Kimmel Cancer Center and other institutions have developed and validated a liquid biopsy that may help identify lung cancer earlier.

Released: 6-Jun-2024 12:05 PM EDT
Minimally invasive blood collection could advance health equity for people experiencing homelessness
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A new study demonstrates that minimally invasive blood collection devices could increase the participation of people experiencing homelessness (PEH) in public health studies and clinical research.

Newswise: 1920_immune-system-cedars-sinai.jpg?10000
Released: 6-Jun-2024 12:05 PM EDT
Cedars-Sinai Investigators Discover Mechanisms of Immunity
Cedars-Sinai

A novel study, led by the Department of Biomedical Sciences at Cedars-Sinai and published today in the peer-reviewed journal Nature, shows how cells use a protein called PD-L1 to rally white blood cells to battle infections.

Released: 6-Jun-2024 12:00 PM EDT
Media Tip Sheet: Honoring the 80th Anniversary of D-Day
George Washington University

World leaders are gathering in Normandy, France, today to honor the 80th anniversary of D-Day. ...

Released: 6-Jun-2024 11:05 AM EDT
Association for Molecular Pathology Publishes Evidence-based Recommendations for Tumor Mutational Burden Testing
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has published a set of evidence-based recommendations for the analytical validation and reporting of tumor mutational burden (TMB) testing as a potential predictive biomarker for immune checkpoint inhibitor (ICI) therapies. These recommendations encompass pre-analytical, analytical, and post-analytical factors of TMB analysis, and emphasize the importance of comprehensive methodological descriptions in publications to allow comparability between assays.

Newswise: UTSW studies clarify link between exercise, risk of heart disease
Released: 6-Jun-2024 11:05 AM EDT
UTSW studies clarify link between exercise, risk of heart disease
UT Southwestern Medical Center

Exercising at a high level doesn’t affect the progression of calcium buildup in the arteries, even among older athletes such as marathoners who tend to have higher coronary artery calcium (CAC) scores, according to new research from UT Southwestern Medical Center. But a longer duration of exercise is associated with higher CAC.

Newswise: ‘Artificial Lymph Node’ Used to Treat Cancer in Mice
Released: 6-Jun-2024 11:00 AM EDT
‘Artificial Lymph Node’ Used to Treat Cancer in Mice
Johns Hopkins Medicine

Johns Hopkins Medicine scientists say they have developed an artificial lymph node with the potential to treat cancer, according to a new study in mice and human cells.

Newswise: El Centro Regional Medical Center Provides Financial and Operational Updates
6-Jun-2024 11:00 AM EDT
El Centro Regional Medical Center Provides Financial and Operational Updates
UC San Diego Health

Partnership between UC San Diego Health and El Centro Regional Medical Center successfully ensures the delivery of high-quality care to Imperial County.

Newswise: Hormone-free barrier contraceptive undergoing clinical trial at UC Davis Health
Released: 6-Jun-2024 10:30 AM EDT
Hormone-free barrier contraceptive undergoing clinical trial at UC Davis Health
UC Davis Health

The UC Davis Department of Obstetrics and Gynecology is recruiting potential participants for a clinical trial of an investigational hormone-free monthly intravaginal method of contraception.

Released: 6-Jun-2024 10:05 AM EDT
Regenerating Damaged Heart Cells
Ann and Robert H. Lurie Children's Hospital of Chicago

Scientists from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago have discovered a way to regenerate damaged heart muscle cells in mice, a development which may provide a new avenue for treating congenital heart defects in children and heart attack damage in adults, according to a study published in the Journal of Clinical Investigation.

Released: 6-Jun-2024 10:05 AM EDT
Breakthroughs in Breast Cancer: Susan G. Komen(R) Scholars and Studies Highlighted at ASCO 2024
Susan G. Komen

Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization, showcased cutting-edge breast cancer research aimed at advancing the field at the ASCO Annual Meeting 2024. Organized by the American Society of Clinical Oncology, this premier conference annually convenes over 40,000 oncologists and stakeholders worldwide.

Newswise:Video Embedded researchers-find-flavor-restrictions-affect-tobacco-buyers-differently-depending-on-socioeconomic-status
VIDEO
Released: 6-Jun-2024 10:05 AM EDT
Researchers find flavor restrictions affect tobacco buyers differently depending on socioeconomic status
Virginia Tech

Restricting menthol flavor in cigarettes while making nicotine replacement therapy, such as a skin patch that can help ease withdrawal, more available and affordable has the potential to reduce socioeconomic disparities in tobacco use.

Newswise: Groundbreaking LLNL and BridgeBio Oncology Therapeutics collaboration announces start of human trials for supercomputing-discovered cancer drug
5-Jun-2024 6:00 PM EDT
Groundbreaking LLNL and BridgeBio Oncology Therapeutics collaboration announces start of human trials for supercomputing-discovered cancer drug
Lawrence Livermore National Laboratory

In a substantial milestone for supercomputing-aided drug design, Lawrence Livermore National Laboratory (LLNL) and BridgeBio Oncology Therapeutics (BridgeBio) today announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer.

   
Newswise: Building a sustainable kidney transplant program in Rwanda
Released: 6-Jun-2024 9:05 AM EDT
Building a sustainable kidney transplant program in Rwanda
Michigan Medicine - University of Michigan

Jeffrey Punch, M.D., a transplant surgeon at University of Michigan Health, has his week-long trips to Rwanda down to an efficient science.He brings just one bag, a carry-on typically packed with a week's worth of underwear, socks and shirts, a jacket, three pairs of pants, a shaving kit and loupes. The pants are worn twice each to save on packing space.

Released: 6-Jun-2024 9:05 AM EDT
Neurent Medical Announces Publication of Positive Long-Term Results from Study on Chronic Rhinitis Treatment
Neurent Medical

Recent study confirms safety and efficacy of NEUROMARK® for chronic rhinitis

Released: 6-Jun-2024 9:05 AM EDT
Innovative Combination Therapy Shows Promise for Bladder Cancer Patients Unresponsive to Standard Treatment
Moffitt Cancer Center

In a groundbreaking advance that could revolutionize bladder cancer treatment, a novel combination of cretostimogene grenadenorepvec and pembrolizumab has shown remarkable efficacy in patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer.



close
0.22558